![Laurence Espinasse](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurence Espinasse
Direktor/Vorstandsmitglied bei
OXFORD BIOMEDICA PLC
Profil
Laurence Espinasse currently works at Oxford Biomedica Plc, as Non-Executive Director from 2024 and Institut Mérieux SA, as General Counsel & Compliance Officer from 2021.
Ms. Espinasse also formerly worked at Transgene SA, as Non-Independent Director, Ernst & Young Audit SAS (France), as Manager-Business Law Department from 2012 to 2013, and MDL Société d’Avocats, as Partner & Head-Business Law Department.
Ms. Espinasse received her graduate degree from Université Blaise Pascal.
Aktive Positionen von Laurence Espinasse
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 24.07.2024 |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Compliance Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Laurence Espinasse
| Unternehmen | Position | Ende |
|---|---|---|
Ernst & Young Audit SAS (France)
 Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Corporate Officer/Principal | 01.01.2013 |
MDL Société D AVOCATS
 MDL Société D AVOCATS Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
| TRANSGENE | Direktor/Vorstandsmitglied | - |
Ausbildung von Laurence Espinasse
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Ernst & Young Audit SAS (France)
Ernst & Young Audit SAS (France) Miscellaneous Commercial ServicesCommercial Services Provides Auditing & Accounting Services | Commercial Services |
Université Blaise Pascal
 Université Blaise Pascal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institut Mérieux SA
Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
MDL Société D AVOCATS
MDL Société D AVOCATS Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
